Kaat Van Aperen

Ms. Kaat Van Aperen

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2023 in Trials
Verified
Journal Article
Open access
PDF file
KAKaat Van Aperen
Kaat Van Aperen
AGAn De Groef
An De Groef
NDNele Devoogdt
Nele Devoogdt
TVTessa De Vrieze
Tessa De Vrieze
TTThierry Troosters
Thierry Troosters
Sandra NuytsSandra Nuyts
Sandra Nuyts
Background: With over 500,000 annually reported cases worldwide, head and neck cancer (HNC) is the seventh most common type of cancer worldwide. Treatment of HNC with chemoradiotherapy frequently results in serious impairments in physical and psychosocial functioning. Besides, HNC patients typically start their cancer treatment already with poor physical and psychosocial health. It has been shown that a sufficient level of physical activity (PA) before, during, and after cancer treatment is associated with fewer negative treatment-related side effects and a better quality of life (QOL). In order to prevent worsening of functioning and limit the physical impact of the HNC treatment, a comprehensive supervised exercise program (CSEP) may be beneficial during early cancer treatment. However, up to now, the feasibility and effectiveness of such a program are not yet investigated thoroughly in HNC. Therefore, the primary objective of this study is to examine the effectiveness of a CSEP during HNC treatment, in addition to usual supportive care, compared to usual supportive care alone, on health-related QOL up to 1 year post-diagnosis. Secondary objectives entail gathering information on (1) the effectiveness of a CSEP on secondary outcomes such as physical and mental function, activities of daily life, and participation in society and (2) the feasibility, possible barriers, and facilitators for participation in a CSEP during HNC treatment. Methods: To investigate the effectiveness of the CSEP, a parallel, open-label randomized controlled trial will be performed. To study the feasibility of the CSEP, a mixed-method study will be performed in a subgroup of participants. HNC patients are eligible if they receive radiotherapy at the Radiation-Oncology department of the University Hospital of Leuven. A 4-size permuted block randomization will be used. The control group receives the current standard of supportive care. The intervention group receives a CSEP, additional to the same usual supportive care. The CSEP consists of a 12-week intensive phase with 3 exercise sessions of 1 h per week, where supervision is gradually reduced after 6 weeks. During the maintenance phase (from week 13), patients exercise at home with monthly tele-consultations with a physiotherapist. The CSEP contains supervised aerobic and resistance training. In both groups, outcomes of interest are evaluated through self-reported questionnaires and clinical assessments, at baseline, 6 weeks, 12 weeks, 6 months, and 12 months post-diagnosis. The primary endpoint is health-related QOL, measured with the EORTC QLQ-C30 at 6 months post-diagnosis. Discussion: The study will be conducted in accordance with the Declaration of Helsinki. This protocol has been approved by the ethical committee of the University Hospitals Leuven (s65549). Recruitment started in January 2022. Results will be disseminated via peer-reviewed scientific journals and presentations at congresses. Trial registration: Trial Registration: ClinicalTrials.gov Identifier: NCT05256238 Date of registration: February 25, 2022

7 September 2025 in Disability and Rehabilitation
Verified
Journal Article
Closed access
KAKaat Van Aperen
Kaat Van Aperen
Sandra NuytsSandra Nuyts
Sandra Nuyts
Nele DevoogdtNele Devoogdt
Nele Devoogdt
TTThierry Troosters
Thierry Troosters
TVTessa De Vrieze
Tessa De Vrieze
AGAn De Groef
An De Groef
This study aims to cross-culturally validate the Dutch version of the Lymphedema Symptom Intensity and Distress Survey-Head and Neck version 2.0 (LSIDS-H&N v2.0). This questionnaire assesses the impact of lymphedema and fibrosis symptoms in head and neck cancer (HNC) patients in terms of symptom intensity and related distress. The convergent validity, test-retest reliability, and internal consistency of the Dutch LSIDS-H&N v2.0 were investigated in 30 HNC patients. Convergent validity was examined by correlating LSIDS-H&N v2.0 scores with four other questionnaires: the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire version 3.0 (EORTC QLQ-C30 v3.0), Brief Pain Inventory Short Form (BPI-SF), Neck Disability Index (NDI), and Vanderbilt Head and Neck Symptom Survey version 2.0 (VHNSS v2.0). Eleven hypotheses were tested. Ten out of 11 hypotheses (91%) were accepted, confirming very strong convergent validity. The Dutch LSIDS-H&N v2.0 demonstrated strong to very strong test-retest reliability (ICCs of 0.792 to 0.963). Very strong internal consistency was demonstrated (Cronbach's α ranging from 0.883 to 0.981). The Dutch LSIDS-H&N v2.0 proved to be a reliable and valid tool for assessing symptom burden and distress in HNC patients with potential lymphedema and/or fibrosis. ClinicalTrials.gov, Identifier: NCT05256238 (S65549).

15 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
KAKaat Van Aperen
Kaat Van Aperen
Sandra NuytsSandra Nuyts
Sandra Nuyts
TTThierry Troosters
Thierry Troosters
Nele DevoogdtNele Devoogdt
Nele Devoogdt
TVTessa De Vrieze
Tessa De Vrieze
AGAn De Groef
An De Groef
Background/Objectives: Head and neck lymphedema (HNL) is a common complication after head and neck cancer (HNC) treatment. Reliable and feasible assessment methods are essential for monitoring and management. This study aimed to evaluate the reliability and clinical feasibility of three methods for assessing external HNL in HNC patients: local tissue water (%) using the MoistureMeterD Compact (MMDC), neck circumference using a tape measure, and dermal thickness using B-mode ultrasound. Methods: Thirty-three HNC patients with potential HNL were included. Measurements were performed on the same day, twice by the same rater and once by a different rater. Intraclass correlation coefficients (ICC2,1), (relative) standard error of measurement ((%)SEM), smallest real difference (SRD), systematic differences across measurement occasions, and Bland–Altman plots with 95% limits of agreement were analyzed. Time efficiency and clinical limitations were assessed. As an exploratory analysis, Spearman correlations among methods were examined. Results: All methods demonstrated moderate to very strong reliability (ICCs2,1 0.781–0.994), except dermal thickness (ICCs2,1 0.136–0.354). Differences between raters and within one rater were not clinically meaningful. Neck circumference showed the highest reliability (ICCs2,1 0.958–0.994) and was the fastest to perform with the fewest limitations. The methods showed weak correlations with each other. Conclusions: Neck circumference was the most reliable and time-efficient method assessing HNL in clinical practice but is limited to the neck region. For the head, local tissue water assessment seems the most reliable and feasible. The methods assess different aspects of HNL. Further research should confirm how these methods can complement each another.

13 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
KVKaat Verbeelen
Kaat Verbeelen
AGAn De Groef
An De Groef
KAKaat Van Aperen
Kaat Van Aperen
CGCeren Gursen
Ceren Gursen
Sandra NuytsSandra Nuyts
Sandra Nuyts
Michel GCAM MertensMichel GCAM Mertens
Michel GCAM Mertens
Background/Objectives: Post-radiation fibrosis is a common complication in patients with head and neck cancer (HNC), characterised by increased tissue stiffness and functional limitations. Shear wave elastography (SWE) enables objective assessment of tissue stiffness, while self-reported outcome measures provide insight into symptom burden. However, the longitudinal evolution of these outcomes and their relationship remains insufficiently described. This study aimed to characterise post-radiation fibrosis over time using objective SWE measurements of sternocleidomastoid (SCM) muscle stiffness and self-reported fibrosis-related symptoms, and to examine their longitudinal association. Methods: This prospective longitudinal study included 56 patients with HNC undergoing primary or postoperative (chemo)radiotherapy. Muscle stiffness was measured using SWE, and fibrosis-related symptoms were assessed with the Lymphoedema Symptom Intensity and Distress Survey-Head and Neck (LSIDS-H&N) at 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after the start of radiotherapy. Longitudinal analyses were performed using mixed-effects models adjusted for surgery and radiation dose, and within-subject associations were evaluated using repeated measures correlation. Results: Muscle stiffness increased over time, with estimated mean stiffness values rising from 4.12 m/s at baseline to 4.76 m/s at 6 months and 4.92 m/s at 12 months. Significant increases were observed at 6 months (p = 0.007) and 12 months (p = 0.012) compared with baseline. In contrast, self-reported fibrosis-related symptoms remained stable, with no significant differences between time points. No significant within-subject association was found between muscle stiffness and self-reported fibrosis-related symptoms (r = −0.13, p = 0.498). Conclusions: Muscle stiffness measured with SWE increased over time following radiotherapy, whereas self-reported fibrosis-related symptoms remained stable. No significant longitudinal association was found between these outcomes, suggesting they may capture different aspects of fibrosis.

6 July 2026 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Closed access
PDF file
KVKaat Verbeelen
Kaat Verbeelen
CGCeren Gursen
Ceren Gursen
KAKaat Van Aperen
Kaat Van Aperen
MMMichel Gcam Mertens
Michel Gcam Mertens
Nele DevoogdtNele Devoogdt
Nele Devoogdt
AGAn De Groef
An De Groef

13 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
KAKaat Van Aperen
Kaat Van Aperen
AGAn De Groef
An De Groef
NDNele Devoogdt
Nele Devoogdt
TVTessa De Vrieze
Tessa De Vrieze
TTThierry Troosters
Thierry Troosters
SNSandra Nuyts
Sandra Nuyts
Background With over 500 000 annually reported cases worldwide, head and neck cancer (HNC) is the seventh most common type of cancer worldwide. Treatment of HNC with chemoradiotherapy frequently results in serious impairments in physical and psychosocial functioning. Besides, HNC patients typically start their cancer treatment already with poor physical and psychosocial health. It has been shown that a sufficient level of physical activity (PA) before, during and after cancer treatment is associated with fewer negative treatmentrelated side effects and a better quality of life (QOL). In order to prevent worsening of functioning and limit the physical impact of the HNC treatment, a comprehensive supervised exercise program (CSEP) may be beneficial during early cancer treatment. However, up to now, the feasibility and effectiveness of such a program are not yet investigated thoroughly in HNC. Therefore, the primary objective of this study is to examine the effectiveness of a CSEP during HNC treatment, in addition to usual supportive care, compared to usual supportive care alone, on health-related QOL up to 1 year post-diagnosis. Secondary objectives entail gathering information on 1) the effectiveness of a CSEP on secondary outcomes such as physical and mental function, activities of daily life and participation in society, 2) the feasibility, possible barriers and facilitators for participation in a CSEP during HNC treatment. Methods To investigate the effectiveness of the CSEP, a parallel, open-label randomized controlled trial will be performed. To study the feasibility of the CSEP, a mixed-method study will be performed in a subgroup of participants. HNC patients are eligible if they receive radiotherapy at the Radiation-Oncology department of the University Hospital of Leuven. A 4-size permuted block randomization will be used. The control group receives the current standard of supportive care. The intervention group receives a CSEP, additional to the same usual supportive care. The CSEP consists of a 12-week intensive phase with 3 exercise sessions of 1-hour per week, where supervision is gradually reduced after 6 weeks. During the maintenance phase (from week 13), patients exercise at home with monthly teleconsultations with a physiotherapist. The CSEP contains supervised aerobic and resistance training. In both groups, outcomes of interest are evaluated through self-reported questionnaires and clinical assessments, at baseline, 6 weeks, 12 weeks, 6 months and 12 months post-diagnosis. The primary endpoint is health-related QoL, measured with the EORTC QLQ-C30 at 6 months post-diagnosis. Discussion The study will be conducted in accordance with the Declaration of Helsinki. This protocol has been approved by the ethical committee of the University Hospitals Leuven (s65549). 3 Recruitment started in January 2022. Results will be disseminated via peer-reviewed scientific journals and presentations at congresses. Trial Registration: ClinicalTrials.gov Identifier: NCT05256238 Date of registration: February 25, 2022